Exposure-Response of Entospletinib (ENTO) for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia

Autor: Gupta, Sneha *, Meng, Amy *, Sharma, Shringi *, Ye, Wei *, Silverman, Jeffrey *, Abella, Esteban M., Mathias, Anita *
Zdroj: In Blood 8 December 2017 130 Supplement 1:1735-1735
Databáze: ScienceDirect